InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ANAPTYSBIO, INC

ANAB Clue Score43
United States Fiscal year ends June CIK 0001370053 Results filed 12 May 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

68
Insider
Date
Role
Action
Shares
Price
Amount
Hollings Renton
1 Oct 2026
Director
Sold after exercise
5,000
$49.87
$249.37K
Eric J Loumeau
11 Feb 2026
Chief Legal Officer
Sold after exercise
10,000
$54.00
$540.00K
Magda Marquet
15 Jan 2026
Director
Sold after exercise
1,710
$48.85
$83.53K
Magda Marquet
15 Jan 2026
Director
Sold after exercise
9,290
$48.12
$447.00K
Eric J Loumeau
22 Dec 2025
Chief Legal Officer
Sold after exercise
10,000
$51.00
$510.00K
Dennis Mulroy
22 Dec 2025
Chief Financial Officer
Sold after exercise
10,000
$50.00
$500.00K
Paul F. Lizzul
22 Dec 2025
Chief Medical Officer
Sold after exercise
1,500
$50.00
$75.00K
Eric J Loumeau
17 Dec 2025
Chief Legal Officer
Sold after exercise
10,000
$46.00
$460.00K
Dennis Mulroy
16 Dec 2025
Chief Financial Officer
Sold after exercise
6,360
$45.21
$287.51K
Dennis Mulroy
16 Dec 2025
Chief Financial Officer
Sold after exercise
9,365
$44.62
$417.82K
Eric J Loumeau
16 Dec 2025
Chief Legal Officer
Sold after exercise
4,195
$45.24
$189.77K
Eric J Loumeau
16 Dec 2025
Chief Legal Officer
Sold after exercise
8,305
$44.68
$371.03K
Eric J Loumeau
30 Sep 2025
Chief Legal Officer
Sold after exercise
8,240
$29.00
$238.96K
Hollings Renton
8 Aug 2025
Director
Sold after exercise
7,121
$19.70
$140.26K
Hollings Renton
8 Aug 2025
Director
Sold after exercise
3,110
$19.44
$60.46K
Hollings Renton
2 Jul 2025
Director
Sold after exercise
13,675
$23.82
$325.78K
Hollings Renton
2 Jul 2025
Director
Sold after exercise
7,250
$23.09
$167.41K
Hollings Renton
29 Nov 2024
Director
Sold after exercise
10,000
$25.00
$250.00K
Paul F. Lizzul
23 Sep 2024
Chief Medical Officer
Sold after exercise
1,500
$38.67
$58.01K
Dennis Mulroy
16 Sep 2024
Chief Financial Officer
Sold after exercise
10,000
$40.13
$401.30K
Dennis Mulroy
16 Sep 2024
Chief Financial Officer
Sold after exercise
2,220
$38.93
$86.42K
Eric J Loumeau
16 Sep 2024
Chief Legal Officer
Sold after exercise
6,500
$40.13
$260.85K
Eric J Loumeau
16 Sep 2024
Chief Legal Officer
Sold after exercise
2,220
$38.93
$86.42K
Paul F. Lizzul
14 Aug 2024
Chief Medical Officer
Sold after exercise
2,000
$40.00
$80.00K
Paul F. Lizzul
18 Jul 2024
Chief Medical Officer
Sold after exercise
1,500
$35.00
$52.50K
Hollings Renton
15 Jul 2024
Director
Sold after exercise
2,897
$30.98
$89.75K
Hollings Renton
15 Jul 2024
Director
Sold after exercise
7,103
$30.50
$216.67K
Eric J Loumeau
16 Feb 2024
Chief Legal Officer
Sold after exercise
5,000
$25.00
$125.00K
Dennis Mulroy
14 Sep 2023
Chief Financial Officer
Sold after exercise
2,105
$19.48
$41.01K
Eric J Loumeau
14 Sep 2023
Chief Legal Officer
Sold after exercise
2,105
$19.48
$41.01K
Paul F. Lizzul
14 Sep 2023
Chief Medical Officer
Sold after exercise
2,105
$19.48
$41.01K
Eric J Loumeau
8 Jun 2022
COO, General Counsel
Sold after exercise
2,500
$24.00
$60.00K
Hamza Suria
20 Dec 2021
President, CEO
Sold after exercise
5,522
$36.40
$201.03K
Hamza Suria
20 Dec 2021
President, CEO
Sold after exercise
19,208
$35.75
$686.78K
Hamza Suria
20 Dec 2021
President, CEO
Sold after exercise
11,915
$34.89
$415.76K
Hamza Suria
5 Nov 2021
President, CEO
Sold after exercise
14,302
$35.00
$500.57K
Eric J Loumeau
4 Nov 2021
COO, General Counsel
Sold after exercise
5,000
$35.00
$175.00K
Hamza Suria
4 Nov 2021
President, CEO
Sold after exercise
6,059
$35.00
$212.07K
Hamza Suria
1 Nov 2021
President, CEO
Sold after exercise
2,559
$32.88
$84.14K
Hamza Suria
1 Nov 2021
President, CEO
Sold after exercise
34,087
$32.27
$1.10M
Hamza Suria
26 Oct 2021
President, CEO
Sold after exercise
15,993
$30.00
$479.79K
Eric J Loumeau
12 Feb 2021
COO, General Counsel
Sold after exercise
10,000
$35.00
$350.00K
Marco Londei
4 Jun 2019
Chief Medical Officer
Sold after exercise
2,003
$74.50
$149.22K
Marco Londei
4 Jun 2019
Chief Medical Officer
Sold after exercise
2,048
$73.43
$150.38K
Marco Londei
4 Jun 2019
Chief Medical Officer
Sold after exercise
6,009
$72.45
$435.36K
Marco Londei
15 Jan 2019
Chief Medical Officer
Sold after exercise
14,894
$70.04
$1.04M
Marco Londei
15 Jan 2019
Chief Medical Officer
Sold after exercise
4,181
$69.29
$289.69K
Hamza Suria
14 Jan 2019
President, CEO
Sold after exercise
12,240
$71.10
$870.30K
Hamza Suria
14 Jan 2019
President, CEO
Sold after exercise
27,760
$70.65
$1.96M
Marco Londei
17 Dec 2018
Chief Medical Officer
Sold after exercise
6,741
$68.47
$461.58K
Marco Londei
17 Dec 2018
Chief Medical Officer
Sold after exercise
8,002
$67.57
$540.68K
Marco Londei
17 Dec 2018
Chief Medical Officer
Sold after exercise
3,185
$66.38
$211.42K
Marco Londei
17 Dec 2018
Chief Medical Officer
Sold after exercise
12,120
$65.36
$792.18K
Hamza Suria
14 Dec 2018
President, CEO
Sold after exercise
7,800
$70.51
$549.98K
Hamza Suria
14 Dec 2018
President, CEO
Sold after exercise
9,084
$69.68
$632.97K
Hamza Suria
14 Dec 2018
President, CEO
Sold after exercise
24,844
$68.89
$1.71M
Hamza Suria
12 Dec 2018
President, CEO
Sold after exercise
8,324
$72.88
$606.62K
Hamza Suria
12 Dec 2018
President, CEO
Sold after exercise
9,673
$71.92
$695.72K
Hamza Suria
12 Dec 2018
President, CEO
Sold after exercise
12,003
$71.11
$853.48K
Hamza Suria
10 Dec 2018
President, CEO
Sold after exercise
4,964
$72.48
$359.81K
Hamza Suria
10 Dec 2018
President, CEO
Sold after exercise
10,347
$71.49
$739.70K
Hamza Suria
10 Dec 2018
President, CEO
Sold after exercise
15,276
$70.57
$1.08M
Dominic Piscitelli
3 Dec 2018
Chief Financial Officer
Sold after exercise
1,100
$75.81
$83.39K
Dominic Piscitelli
3 Dec 2018
Chief Financial Officer
Sold after exercise
6,624
$74.33
$492.36K
Dominic Piscitelli
3 Dec 2018
Chief Financial Officer
Sold after exercise
2,298
$73.18
$168.16K
Dominic Piscitelli
3 Dec 2018
Chief Financial Officer
Sold after exercise
4,820
$72.24
$348.21K
Dominic Piscitelli
3 Dec 2018
Chief Financial Officer
Sold after exercise
18,604
$71.33
$1.33M
Dominic Piscitelli
3 Dec 2018
Chief Financial Officer
Sold after exercise
3,554
$70.34
$249.97K
Show all 180 transactions →

What was left out

Form 4 filings counted 265
Amendments (4/A) skipped 1
Filings about a different issuer 1
Unreadable filings 0
Joint filings 11
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 68
Sales at will 66
Transactions with no price 0
Shares from compensation/vesting 22,378,949
Sales filed before the plan box existed 26
History held since 31 Jan 2017